General Information
Age Group
Adults ages 40 and olderStatus
RecruitingProtocol Number
NCT04618809
Background Information
The purpose of this research study is to enhance the care of the older patient with mGC/mEC/mGEJC. The study will evaluate the benefit of incorporating geriatric assessments into the routine care of patients.
Offered At
Inova Schar Cancer Institute
8081 Innovation Park Drive
Fairfax, VA 22031
A department of Inova Fairfax Hospital
Eligibility Information
- Adults age 70 and older
- Ability to read and understand English, ability to sign consent, and complete a self-assessment evaluation
- Evidence of metastatic gastric cancer (mGC), metastatic esophageal cancer (mEC), or metastatic gastroesophageal junction cancer (mGEJC). Patients can be enrolled at any stage of their treatment or disease course
- Ongoing active therapy for mGC. Patients can be treated with any type of therapy including chemotherapy, immunotherapy or Her-2 targeted therapy
- Life expectancy ≥3 months
- Additional eligibility in protocol
Ineligibility Information
- ≤69 years old (participants may be eligible at a later date)
- Inability to read and understand English
- No evidence of mGC (participants may be eligible if evidence of mGC occurs)
- Not on active therapy
- Life expectancy <3 months
- Additional ineligibility in protocol
Additional information can be found at: https://clinicaltrials.gov/ct2/show/NCT04618809